Yuffa Ilya 4
4 · ELI LILLY & Co · Filed Feb 3, 2026
Research Summary
AI-generated summary of this filing
Eli Lilly EVP Ilya Yuffa Converts RSUs; Withholds 1,512 Shares
What Happened
- Ilya Yuffa, EVP & President, LLY USA & Global Capabilities at Eli Lilly (LLY), had 3,394 restricted stock units (RSUs) convert to common shares on Feb 1, 2026 (reported on Form 4 filed Feb 3, 2026).
- Of the 3,394 shares that vested/converted, 1,512.364 shares were withheld to cover taxes (transaction code F) at an effective price of $1,037.15 per share, totaling $1,568,548. The RSU conversion (transaction code M) is recorded at $0 (no cash exercise price).
- Net shares retained by Yuffa after withholding: 3,394 − 1,512.364 = 1,881.636 shares (calculation based on the filing).
Key Details
- Transaction date: 2026-02-01. Form filed: 2026-02-03 (within the normal 2-business-day Form 4 reporting window).
- Actions recorded: M (exercise/conversion) — 3,394 RSUs converted to shares; F (tax withholding) — 1,512.364 shares disposed/withheld to satisfy tax withholding.
- Withheld shares price and value: $1,037.15 per share; total withholding value $1,568,548.
- Footnote: F1 — each restricted stock unit represents a contingent right to receive one share of Eli Lilly common stock.
- Shares owned after the transaction: not specified in the provided excerpt of the filing.
Context
- This was not an open-market buy or sell for cash. It was an RSU vesting/conversion with shares withheld to cover taxes (a common, routine "net settlement" of equity awards).
- For retail investors: such tax-withholding dispositions are routine and do not necessarily indicate the insider's view on the company's stock. They are different from voluntary sales or purchases.
Insider Transaction Report
Form 4
Yuffa Ilya
EVP&Pres, LLY USA&Global Capab
Transactions
- Exercise/Conversion
Common Stock
2026-02-01+3,394→ 29,653.971 total - Tax Payment
Common Stock
2026-02-01$1037.15/sh−1,512.364$1,568,548→ 28,141.607 total - Exercise/Conversion
Restricted Stock Unit
[F1]2026-02-01−3,394→ 0 totalFrom: 2026-02-01Exp: 2026-02-01→ Common Stock (3,394 underlying)
Footnotes (1)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
Signature
/s/ Jonathan Groff for Ilya Yuffa, pursuant to authorization on file|2026-02-03